type here...

CATEGORIES

Obesity

LATEST

1234Page 4 of 4

TRENDING

EDITORS CHOICE

GLP‑1 Medications in Later Life: Why the “Miracle Shot” Needs a Senior‑Specific Safety Lens

Pat Farrell PhD -
When GLP-1 medications like semaglutide began to gain attention, many people saw them as a breakthrough. For some people, these drugs help lower blood sugar,...

Conceptually, the “Make America Healthy Again Movement” Needs a Nod

Gil Bashe, Medika Life Editor -
The health innovation paradox – breakthrough medications and dedicated providers. We spend more and live fewer years than other nations.

2024 Health Trends: Progress, Challenges, and Opportunities

Gil Bashe, Medika Life Editor -
Here are 10 health-sector developments—not ranked—to watch in the coming year, determined by media coverage, reader interest, and personal interest.

AI-Powered Obesity Care: FlyteHealth Delivers Big Wins for Connecticut’s Public Employees

Medika Life -
In an era where access to effective obesity care remains mired in controversy over medication costs and payer reluctance, a promising model is gaining...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories